Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4)

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

2,056

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2026

Conditions

Breast Cancer

Interventions

DRUG

Letrozole

letrozole for 2-3 years after Tam

DRUG

Letrozole

Letrozole for 5 years after Tam

Trial Locations (1)

Istituto Nazionale per la Ricerca sul Cancro, Genoa

All Listed Sponsors

lead

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

OTHER